Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

No association between glutathione peroxidase Pro198Leu polymorphism and breast cancer risk.

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology - 1 Oct 2005

Ahn Jiyoung, Gammon Marilie D, Santella Regina M, Gaudet Mia M, Britton Julie A, Teitelbaum Susan L, Terry Mary Beth, Neugut Alfred I, Ambrosone Christine B

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Breast Neoplasms
Share to Genotype
Share to Glutathione Peroxidase

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Glutathione Peroxidase GPX1

Share to Polymorphism, Genetic

Source

Identifiers

PMID: 16214934
DOI: 10.1158/1055-9965.EPI-05-0459

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

No association between glutathione peroxidase Pro198Leu polymorphism and breast cancer risk.PMID 16214934Read ↗

No association between GPX1 Pro198Leu and breast cancer risk.Semantic proximity Read ↗

No association between OGG1 Ser326Cys polymorphism and breast cancer risk.Semantic proximity Read ↗

Association between glutathione peroxidase 1 codon 198 variant and the occurrence of breast cancer in Rwanda.Semantic proximity Read ↗

GPX1 Pro198Leu polymorphism and breast cancer risk: a meta-analysis.Semantic proximity Read ↗

No evidence for glutathione S-transferases GSTA2, GSTM2, GSTO1, GSTO2, and GSTZ1 in breast cancer risk.Semantic proximity Read ↗

Associations between GPX1 Pro198Leu polymorphism, erythrocyte GPX activity, alcohol consumption and breast cancer risk in a prospective cohort study.Semantic proximity Read ↗

MnSOD polymorphism and breast cancer in a population-based case-control study.Semantic proximity Read ↗

No association between a single nucleotide polymorphism in CYP19 and breast cancer risk.Semantic proximity Read ↗

Functional Ser326Cys polymorphism in the hOGG1 gene is not associated with breast cancer risk.Semantic proximity Read ↗

Genetic variants of GPX1 and SOD2 and breast cancer risk at the Ontario site of the Breast Cancer Family Registry.Semantic proximity Read ↗

No association between matrix metalloproteinase-1 or matrix metalloproteinase-3 polymorphisms and breast cancer susceptibility: a report from the Shanghai Breast Cancer Study.Semantic proximity Read ↗

No association between CYP1B1 Val432Leu polymorphism and breast cancer risk: a meta-analysis involving 40,303 subjects.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.